of cAMP in the short-term modulation of a neuromuscular system in Aplysia. J. Neurophysiol. 83: 1567Neurophysiol. 83: -1579Neurophysiol. 83: , 2000. Neuromuscular synapses in buccal muscle I3a of Aplysia are modulated by the small cardioactive peptide (SCP), a peptide cotransmitter that is intrinsic to the motor neurons, and by serotonin (5-HT) released from modulatory neurons that are extrinsic to the motor circuit. Although the modulation of excitatory junction potentials (EJPs) and contractions by 5-HT and SCP has been studied extensively in this muscle, little is known about the mechanisms that underlie the modulation. 5-HT and SCP, at 1 M, were found to potently increase the level of cAMP in I3a. Therefore we investigated whether the activation of the cAMP pathway was sufficient to modulate EJPs and contractions. The direct activation of adenylyl cyclase with forskolin increased the level of cAMP, facilitated EJPs, and potentiated contractions. Indeed, the short-term effects of forskolin were very similar to all aspects of the short-term effects of 5-HT and SCP. Membrane-permeable cAMP analogues also mimicked the effects of 5-HT and SCP on EJPs and contractions. However, it seems likely that some effects of 5-HT are also mediated through other second-messenger pathways because low concentrations of 5-HT modulate EJPs and contractions but do not significantly increase cAMP levels in I3a. It is possible that lower concentrations of 5-HT function through receptors linked to protein kinase C (PKC) because phorbol, an activator of PKC, modulated EJPs and contractions without increasing the levels of cAMP. In conclusion, we provide evidence that pharmacological agents that activate the cAMP pathway mimicked most of the effects of 5-HT or SCP and that more than one second-messenger system appears to be involved in the modulation of the I3a neuromuscular system.
I N T R O D U C T I O N
One mechanism utilized by the nervous system to modify behavior is the modulation of synaptic transmission. There is increasing evidence that major sites for this modulation in both vertebrates and invertebrates are peripheral at neuromuscular synapses (Calabrese 1989; Worden 1998) . Peripheral modulation has been examined extensively in the muscles that control feeding movements in Aplysia (Weiss et al. 1992 (Weiss et al. , 1993 Whim et al. 1993 ). Many of the motor neurons that drive ingestive and egestive movements have been identified, and all of them express modulatory peptide cotransmitters Lloyd 1991, 1994; Cohen et al. 1978; Gardner 1971) . In addition, buccal muscle is innervated by purely modulatory serotonergic neurons termed the metacerebral cells (MCCs) . Therefore these muscles are modulated by neuropeptides intrinsic to the motor neurons and by serotonin (5-HT) released from modulatory neurons that are extrinsic to the motor circuit (Church and Lloyd 1994; Church et al. 1993; Cropper et al. 1987 Cropper et al. , 1990 Lloyd et al. 1984 Lloyd et al. , 1987 Weiss et al. 1978; Lloyd 1989, 1990) .
The preparation we have chosen to study consists of a muscle (termed the intrinsic anterior muscle 3, I3a) that participates in the closing of the jaws. It is innervated by two identified excitatory motor neurons B3 and B38, which use glutamate as their fast transmitter and also express modulatory peptide cotransmitters; B3 expresses FMRFamide, and B38 expresses the small cardioactive peptides (SCP). All the muscle fibers in I3a are functionally innervated by both motor neurons; however, we do not know whether individual fibers are anatomically innervated by both neurons because the muscle fibers are electrically coupled (Church and Lloyd 1991; Church et al. 1993; Fox and Lloyd 1999; Lotshaw and Lloyd 1990) . I3a is also innervated by the two MCCs, a bilateral pair of large serotonergic neurons that have extensive central and peripheral synaptic outputs (Eisenstadt et al. 1973; Weinreich et al. 1973; Weiss and Kupfermann 1976) . Release of peptides from the motor neurons and 5-HT from the MCCs acts peripherally to modulate excitatory junction potentials (EJPs) and contractions of I3 Fox and Lloyd 1998; Keating and Lloyd 1999; Lotshaw and Lloyd 1990) . Specifically, these modulatory transmitters enhance the speed and strength of biting responses. EJPs and contractions of I3a muscle fibers are also modulated by application of exogenous neuropeptide cotransmitters and 5-HT Fox and Lloyd 1997; Lotshaw and Lloyd 1990) . In previous studies, we have concentrated on the actions of 5-HT and SCP. Both modulators produce similar short-term effects including the following: the selective facilitation of B38-evoked EJPs; an increase in the amplitude and relaxation rate of contractions evoked by either B3 or B38; and a decrease in the latency between the onset of a motor neuron burst and the onset of the resulting contraction, which is larger for B38 than for B3.
We continue our study of the I3a neuromuscular system in an attempt to determine the second-messenger pathways that are involved in mediating the effects of 5-HT or SCP. Because they have similar short-term effects on EJPs and contractions, it is possible that they act through the same second-messenger system. We concentrated on the cAMP pathway because cAMP levels in I3a are increased by the exogenous application of 5-HT or SCP as well as by release of endogenous SCP from motor neurons when they are stimulated in a manner similar to their activity recorded during feeding-like motor patterns (Church and Lloyd 1994; Church et al. 1993; Keating and Lloyd 1999; Lotshaw and Lloyd 1990 ). In addition, cAMP working through protein kinase A (PKA) has been shown to mediate many, but not all, of the effects of 5-HT and SCP in another Aplysia buccal muscle preparation (Brezina et al. 1994a,b; Probst et al. 1994 ). Here we provide evidence that the cAMP pathway mediates most of the effects of SCP and some of the effects of 5-HT in I3a. However, it seems likely that some of the effects of 5-HT are also mediated through other pathways.
M E T H O D S

Animals
Aplysia californica (60 -300 g) were obtained from Marinus (Long Beach, CA), maintained in circulating artificial sea water (ASW) at 16°C, and fed dried seaweed every 3 days.
Neuron stimulation
Detailed experimental methods have been described previously (Fox and Lloyd 1997) . Briefly, animals were immobilized with an injection of isotonic MgCl 2 and the dissection carried out in high Ca 2ϩ (33 mM; 3 times normal), high Mg 2ϩ (165 mM; 3 times normal) ASW (termed high Ca, Mg ASW). The buccal mass and buccal ganglia were removed and the mass bisected along the midline. Buccal nerve 2, which contains the peripheral axons of B3 and B38, was left intact (nerve designations from Gardner 1971; muscle nomenclature from Howells 1942; also see Lloyd 1988) . The ganglia were desheathed and superfused with low Ca 2ϩ (0.5 mM; 0.05 times normal) high Mg 2ϩ (110 mM; 2 times normal) ASW (termed low Ca ASW). Neurons were normally impaled with two microelectrodes (2-4 M⍀; filled with 3 M K acetate), one to inject current and one to monitor membrane potential. B3 and B38 were identified by their position, size, and muscle innervation patterns . All experiments were performed at room temperature (ϳ22°C). Individual spikes in motor neurons were driven by brief (10 -20 ms) depolarizing current pulses. The frequency of action potentials within a burst was usually 16 Hz. The burst durations were adjusted so that the compound EJPs or contractions evoked by B3 or B38 were similar in amplitude. Many experiments were carried out by alternatively stimulating bursts in B3 and B38 at 50-s intervals (100-s intervals for each neuron). These long interburst intervals were used to minimize release of endogenous peptide cotransmitters and posttetanic potentiation Lotshaw and Lloyd 1990; Whim and Lloyd 1990) .
Measurement of I3a contractions
The bath containing the I3a muscle was superfused with ASW and was separated from the ganglia by a partition through which ran the intact nerve containing the axons of the motor neurons. Transmitters and/or pharmacological agents were dissolved in ASW and applied via the superfusion. Typical application periods were 20 min to ensure adequate penetration into the muscle. Note that the partition prevented the ganglia from being exposed to these substances. Contraction amplitudes were monitored with an isotonic transducer (Harvard Apparatus), and submaximal contractions were evoked by stimulating B3 or B38. Burst durations were adjusted (from 0.5 to 4 s) so that contractions evoked by B3 or B38 were similar in amplitude.
Measurement of I3a EJPs
EJPs were recorded with a perfusion electrode Fox and Lloyd 1997) . The perfusion electrode consisted of a small chamber (100 l) and aperture (ϳ1.5 mm) that was positioned to press firmly down on a portion of the muscle (see Fig. 1 in . The inside of this electrode was perfused with ASW, whereas the rest of the preparation was superfused with low Ca ASW to suppress synaptic transmission and muscle contractions. This procedure confined the contractions to the small area of the muscle covered by the recording chamber and thus markedly reduced movement artifacts in the recordings. The earliest evoked muscle contractions occur after the sixth EJP so the early EJPs in a burst are recorded in the absence of any movement. EJPs were recorded by extracellular electrodes placed inside and just outside the wall of the perfusion apparatus. Signals were amplified using a Grass P15D AC amplifier. Transmitters and/or pharmacological agents were applied in ASW to the inner chamber of the perfusion electrode so the ganglia and the remainder of the muscle were not exposed to these substances. Typical application periods were also 20 min. This procedure permits us to simultaneously record from a population of muscle fibers thereby reducing sampling bias. Burst durations were adjusted (from 0.15 to 2 s) so that the compound EJPs evoked by B3 or B38 were similar in amplitude.
Measurement of cAMP
Muscle segments were dissected in high Ca, Mg ASW, weighed (ϳ3 mg each), and washed in several changes of ASW for 1 h. Segments were incubated in ASW, transmitter, or pharmacological agents for 20 min (the same period used in most physiological experiments), extracted immediately in 2% 2N HCl in ethanol at Ϫ30°C
, homogenized, and centrifuged at 10,000 ϫ g. The supernatants were used for duplicate cAMP determinations using a commercial radioimmunoassay (Biomedical Technologies, Norwood, MA).
R E S U L T S
5-HT and SCP increase the level of cAMP in isolated I3a
Brief application (5.5 min) of both 5-HT and SCP potently increase cAMP levels in the I3a muscle (Lotshaw and Lloyd 1990) . However, in subsequent physiological experiments, we found that 20-min applications of the modulators were necessary to maximally facilitate EJPs or potentiate contractions Lloyd 1997, 1998) . Accordingly, we repeated the cAMP measurements using 20-min applications. At 1 M, both 5-HT and SCP dramatically increased the level of cAMP in I3a muscle segments more than 250-fold over control (Fig.  1) . The cAMP levels were ϳ10-fold higher measured after 20 min than those reported by Lotshaw and Lloyd (1990) for the shorter incubation suggesting that the levels of cAMP continue to rise. Lower concentrations of SCP (0.1 M) were also effective at increasing cAMP levels (46 Ϯ 13-fold increase over control, this is equivalent to a 4,500% increase, n ϭ 8), but 0.1 M 5-HT had no significant effect on these levels (20 Ϯ 11% increase, mean Ϯ SE, n ϭ 5; P Ͼ 0.05, t-test; Fig.  1 ). This steep dose response curve for 5-HT, in which 0.1 M essentially has no effect on cAMP levels and 1 M has very large effects, has also been observed in a previous study (Lotshaw and Lloyd 1990 ). Because 0.1 M 5-HT had large effects on EJPs and contractions (Fox and Lloyd 1998) , this suggests that 5-HT may act through mechanisms other than the cAMP pathway. This preparation contains both muscle fibers and the axons and terminals of neurons that innervate them. The large increases in cAMP levels are of such a magnitude that they must occur in the muscle fibers because they constitute nearly the total volume of the muscle. It is unlikely that an increase in cAMP exclusively in the axons and terminals of neurons could account for the measured increase in cAMP levels because of their small volume. This conclusion is supported by work on another buccal muscle in Aplysia (termed I5 or ARC). 5-HT and SCP increase the level of cAMP in dissociated I5 muscle fibers and modulate their whole cell currents recorded by voltage clamp (Brezina et al. 1994a,b) . Although most of the increase in cAMP must be in the muscle fibers, it is possible that the cAMP levels are also increased in the axons or terminals of the motor neurons.
Forskolin selectively facilitates B38-evoked EJPs and modulates contractions of both neurons
Superfusion with 5-HT or SCP has a number of effects including facilitation of EJPs, potentiation of contractions, increased rate of muscle relaxation, and a decrease in the latency between the onset of a burst and the onset of the evoked contraction (Fox and Lloyd 1997) . Although 5-HT and SCP had similar effects on the amplitude of contractions evoked by both motor neurons, they facilitated B38-evoked EJPs much more than those of B3. If cAMP mediates all of the actions of 5-HT and SCP, then activators of the cAMP pathway should also mimic these effects. We focused on the facilitation of EJPs to screen the effects of activators of the cAMP pathway. Because B38-evoked EJPs are potently facilitated by the 5-HT and SCP, they served as a sensitive assay for the effects of the reagents tested, whereas B3-evoked EJPs, which are only slightly facilitated, served as a control for possible nonspecific effects.
Elevation of cAMP levels by activation of adenylyl cyclase with forskolin selectively facilitated B38-evoked EJPs in a concentration-dependent manner. At 10 M, forskolin slightly facilitated B3-evoked EJPs and potently facilitated those of B38 (Figs. 2 and 3) . We believe that this selective facilitation was caused by the activation of adenylyl cyclase because 10 M forskolin increased the levels of cAMP in I3a muscle segments by 191 Ϯ 46% (n ϭ 8) and a forskolin analogue that does not activate adenylyl cyclase but has many of forskolin's nonspecific effects (10 M 1,9-dideoxy-forskolin) (Laurenza FIG. 1. Serotonin (5-HT) and small cardioactive peptide (SCP) increase cAMP levels in I3a muscle segments. 5-HT or SCP (1 M; n ϭ 25 for 5-HT; n ϭ 14 for SCP; P Ͻ 0.01 for both) increased the level of cAMP to a similar degree. Lower concentration of SCP (0.1 M; n ϭ 8; P Ͻ 0.01) also dramatically increased the cAMP levels, but 5-HT, at this concentration (0.1 M; n ϭ 5; P Ͼ 0.05), had no significant effect. cAMP levels were normalized to control muscle segments taken from the same animal and incubated in artificial sea water (ASW). Values are means Ϯ SE. FIG. 2. Effects of forskolin on excitatory junction potentials (EJPs) recorded extracellularly in I3a muscle with a perfusion electrode. A: forskolin (10 M) selectively facilitated B38-evoked EJPs, whereas it had little effect on those of B3. B: dideoxy-forskolin (10 M), a forskolin analogue that does not activate adenylyl cyclase but has many of forskolin's nonspecific effects, had a much smaller effect, suggesting that the selective facilitation was caused by the activation of adenylyl cyclase. EJPs were evoked by alternating stimulation of B3 or B38 (interburst interval of 50 s). Bursts were at 16 Hz, and the burst durations were adjusted so the control compound EJPs evoked by both neurons were similar in amplitude. Recordings are from the same experiment. Pooled results are presented in Fig. 3 . FIG. 3. Summary of the effects of adenylyl cyclase activators on extracellularly recorded EJPs. Forskolin (n ϭ 3 for 1 M; n ϭ 8 for 10 M) and its derivatives that activate adenylyl cyclase, 7-deacetyl-6-(N-acetylglycyl)-forskolin (75 M; DAAG; n ϭ 2) and 7-deacetyl-7-(O-(N-methylpiperazino)-␥-butyryl)-forskolin (100 M; DMPB; n ϭ 2) only slightly facilitated B3-evoked EJPs, whereas they dramatically facilitated B38-evoked EJPs. An inactive derivative of forskolin, 1,9-dideoxy-forskolin (10 M; n ϭ 4 for B3 and n ϭ 3 for B38), had a much smaller effect. The mean amplitude of the 3rd EJPs in the bursts were used because the 1st EJP was often too small to measure reliably (e.g., Fig. 2 ). Increases were calculated using the EJP amplitude before the application of the test agent as the control. et al. 1989) had a much smaller effect on EJPs (Figs. 2 and 3 ). Lower concentrations of forskolin (1 M) also facilitated the B38-evoked EJPs more than those of B3 (Fig. 3) . Two other active forskolin derivatives were tested; 7-deacetyl-6-(Nacetylglycyl)-forskolin (DAAG; 75 M) because it has fewer nonspecific effects than forskolin (Baxter and Byrne 1990b) and 7-deacetyl-7-(O-(N-methylpiperazino)-␥-butyryl)-forskolin (DMPB; 100 M) because it is more soluble and more stable in water (Laurenza et al. 1987) . As reported elsewhere, it was necessary to use higher concentrations of these forskolin derivatives because they are less effective than forskolin at activating adenylyl cyclase (Baxter and Byrne 1990b; Laurenza et al. 1987) . Both DAAG and DMPB facilitated B38-evoked EJPs much more than those of B3 (Fig. 3) . Therefore forskolin and its analogues that activate adenylyl cyclase selectively facilitated B38-evoked EJPs, presumably by increasing cAMP levels.
Because forskolin mimicked the effects of 5-HT and SCP on EJPs, we next examined whether it also modulated evoked contractions. At 10 M, forskolin potentiated both B3-and B38-evoked contractions (by 850 Ϯ 88% for B3, n ϭ 4; by 1,455 Ϯ 420% for B38, n ϭ 5; Fig. 4 ). It also increased the relaxation rate of the contractions and reduced the latency between the onset of the motor neuron burst and the onset of the evoked contraction. The relaxation of the contractions was well fitted to a single exponential, and the time constant was calculated only for regions in which the amplitude of control and potentiated contractions overlapped. Forskolin reduced the relaxation time constant by 32 Ϯ 8% (n ϭ 4) for contractions evoked by B3 and by 29 Ϯ 14% for those evoked by B38 (n ϭ 5). As for the effects of 5-HT and SCP, it is difficult to measure small changes in the relaxation rate because of the large change in the contraction amplitude. The effects of forskolin on the latency were similar to the application of 5-HT or SCP in that the latency was reduced more for B38-evoked contractions than those of B3. The latency of B3-evoked contractions were reduced by 20 Ϯ 7% (n ϭ 4), whereas the B38-evoked contractions were reduced by 54 Ϯ 5% (n ϭ 5; Fig. 4 ). These effects of forskolin appeared to be caused by activation of adenylyl cyclase because 1,9-dideoxy-forskolin (10 M) had little effect on the amplitude, latency, or relaxation rate of contractions (Fig. 4) . Thus the effects of forskolin were similar to the effects of 5-HT and SCP: it increased the level of cAMP, it selectively facilitated B38-evoked EJPs, it potentiated B38-evoked contractions somewhat more than those evoked by B3, it reduced the latency more for B38 than B3, and it increased the relaxation rate of contractions for both neurons. These observations, combined with the effects of 5-HT and SCP on cAMP levels, suggest that these modulators act, at least in part, through the cAMP pathway.
Membrane-permeable cAMP analogues selectively facilitate B38-evoked EJPs and modulate contractions of both neurons
We next investigated whether membrane-permeable cAMP analogues selectively facilitated B38-evoked EJPs. We used a FIG. 4. Effects of forskolin on I3a muscle contractions. Muscle contractions were evoked by alternately stimulating B3 or B38 (interburst interval of 50 s). Bursts were at 16 Hz, and the burst durations were adjusted so control contractions evoked by B3 and B38 were of similar amplitude. A: forskolin (10 M) potentiated both B3-and B38-evoked contractions to a similar degree. The duration of bursts evoked in B3 was 3.5 s, and those in B38 was 4 s. B: forskolin (10 M) reduced the latency between the onset of the motor neuron burst (vertical line) and the onset of the contraction (filled triangle). The latency to the onset of muscle contractions is emphasized by superimposing recordings of the control and modulated contractions at a fast time base and high gain. As a result, most of the contractions are off scale. Superfusion with forskolin increased the amplitude of muscle contractions evoked by both B3 and B38 (apparent as an increased rate of rise in the contraction traces, also see A), but the latency was reduced much more dramatically for contractions evoked by B38 than it was for contractions evoked by B3. The duration of bursts evoked in B3 was 4 s and in B38 was 2 s. C: dideoxy-forskolin (10 M) had little effect on contractions evoked by B3 and B38, suggesting that the potentiation of contractions by forskolin was caused by the activation of adenylyl cyclase. The duration of bursts evoked in B3 was 3.5 s and those in B38 was 4 s. D: dideoxy-forskolin (10 M) also had no effect on latency. The duration of bursts evoked in B3 was 3.5 s, and those in B38 was 4 s. cAMP analogue, cpt-cAMP, that has been used extensively in Aplysia and other animals (Baxter and Byrne 1990a; Goldsmith and Abrams 1992; Rydel and Greene 1988; Weiss et al. 1979) . Two concentrations (100 and 500 M) were tested and found to facilitate EJPs evoked by B38 more than those evoked by B3 (Figs. 5 and 6 ). The facilitation does not appear to be mediated by the extracellular effects of cpt-cAMP because cAMP (500 M), which poorly diffuses across the cell membrane (Sandberg et al. 1991) , had no effect on EJPs. Because cpt-cAMP is hydrolyzed by phosphodiesterases (Sandberg et al. 1991) and high concentrations of it have nonspecific effects on ion channels (Brezina et al. 1994a,b; Lambert and Harrison 1990; Sugita et al. 1994a) , we tried to reduce these effects by using the lower concentration while simultaneously slowing its degradation with phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX). The facilitation of EJPs produced by 100 M cpt-cAMP was significantly enhanced by IBMX. Simultaneous application of IBMX (100 M) with cpt-cAMP selectively facilitated B38-evoked EJPs much more effectively than either cpt-cAMP or IBMX alone (Fig. 6) . We believe that this facilitation was caused by the activation of PKA and not the extracellular actions of cpt-cAMP or IBMX because the coapplication of structurally related molecules, cAMP and adenosine (each at 100 M), had no effect on EJPs. In addition, the purinergic receptors agonists ATP and adenosine (each at 100 M) did not facilitate EJPs. FIG. 5. Effects of cAMP analogues on EJPs recorded extracellularly in I3a muscle with a perfusion electrode. A: cpt-cAMP (500 M). B: mixture of cpt-cAMP (100 M) and 3-isobutyl-1-methylxanthine (IBMX; 100 M). C: Sp-5,6-dichloro-1-␤-D-ribofuranosylbenzimidazole-3Ј,5Ј-monophosphorothioate (BiMPS; 100 M) facilitated EJPs evoked by B38 much more than those evoked by of B3. EJPs were evoked by alternating stimulation of B3 or B38 (interburst interval of 50 s). Bursts were at 16 Hz, and the burst durations were adjusted so control compound EJPs evoked by stimulating both neurons were similar in amplitude. Recordings for A-C are from different experiments. Pooled results are presented in Fig. 6 . FIG. 6. Summary of the effects of cpt-cAMP, cpt-cGMP, and IBMX on EJPs. A: cpt-cAMP alone (n ϭ 8 for 100 M; n ϭ 4 for 500 M), IBMX alone (100 M; n ϭ 15) or a mixture of cpt-cAMP and IBMX (each at 100 M; n ϭ 8 for B3 and n ϭ 9 for B38) facilitated B38-evoked EJPs more than those of B3. Note that the effects of cpt-cAMP were amplified by co-application with IBMX (100 M), a phosphodiesterase inhibitor. B: the mixture of cpt-cAMP and IBMX was more effective at facilitating B38-evoked EJPs than IBMX alone or the mixture of cpt-cGMP and IBMX when compared on the same preparations (n ϭ 4). The mean amplitude of the third EJPs in the bursts were used because the first EJP was often too small to measure reliably (e.g., Fig. 5 ). Increases were calculated using the EJP amplitude before the application of the test agent as the control.
Our working hypothesis was that cpt-cAMP and IBMX were activating PKA. However, it was possible that they were acting through the cGMP pathway because both cpt-cAMP and IBMX inhibit the cGMP-specific phosphodiesterases leading to an elevation of cGMP levels, and cpt-cAMP directly activates cGMPdependent protein kinase (PKG) (Beavo and Reifsnyder 1990; Connolly et al. 1992; Gillespie and Beavo 1989; Sandberg et al. 1991) . We tested for this by using a second more specific activator of PKA and by comparing the effects of PKA and PKG activators on the same preparations. Sp-5,6-dichloro-1-␤-D-ribofuranosylbenzimidazole-3Ј,5Ј-monophosphorothioate (cBiMPS), is a potent and specific activator of PKA (Schultz et al. 1994 ). It is not necessary to use IBMX in these experiments because cBiMPS is resistant to hydrolysis by phosphodiesterases (Sandberg et al. 1991) . cBiMPS (100 M) facilitated B3-evoked EJPs by 122 Ϯ 51%, whereas it dramatically facilitated B38-evoked EJPs by 1,442 Ϯ 999% (n ϭ 3; B38-evoked EJPs were facilitated in all the experiments; however, the facilitation was quite variable ranging from a minimum of a 4-fold to a maximum of 35-fold; Fig. 5 ). Thus a second agent that directly activates PKA mimicked the short-term effects of 5-HT and SCP by selectively facilitating B38-evoked EJPs. Although cpt-cAMP can activate the cGMP pathway by inhibiting cGMP-specific phosphodiesterase and directly activating PKG, the effects of cpt-cGMP are more specific in that it is a poor inhibitor of phosphodiesterases and a poor activator of PKA (Connolly et al. 1992; Francis et al. 1988; Sandberg et al. 1991) . Therefore the contribution of the cGMP pathway to the facilitation produced by cpt-cAMP can be determined by comparing the effects of cpt-cAMP to those of cptcGMP. In four experiments, the effects of IBMX alone, a cptcAMP/IBMX mixture, and a cpt-cGMP/IBMX mixture were compared on the same preparation and found to selectively facil- FIG. 7. Effects of the mixture of cpt-cAMP and IBMX on I3a muscle contractions. Muscle contractions were evoked by alternately stimulating B3 or B38 (interburst interval of 50 s). All bursts were at 16 Hz, and the burst durations were adjusted so contractions evoked by B3 and B38 were of similar amplitude. A: the cpt-cAMP/IBMX mixture (each at 100 M) potentiated both B3-and B38-evoked contractions. Note that unlike 5-HT and SCP, the cptcAMP/IBMX mixture potentiated the B3-evoked contractions more than those of B38. The duration of the bursts evoked in B3 was 1.6 s and bursts evoked in B38 was 2 s. B: the cpt-cAMP/IBMX mixture reduced the latency for contractions evoked by both neurons. The latency to the onset of muscle contractions is emphasized by superimposing recordings of the control and modulated contractions at a fast time base and high gain. The duration of the bursts evoked in B3 was 3.4 s, and those evoked in B38 was 2 s. Recordings for A and B are representative examples from different experiments. Pooled results are presented in Fig. 8 . A, ASW; c/I, cpt-cAMP/IBMX mixture. FIG. 8. Summary of the effects of cpt-cAMP and IBMX on contraction amplitude, latency, and relaxation time constant. A: contractions evoked by B38 were potentiated by IBMX (100 M; n ϭ 4 for B3 and n ϭ 7 for B38), but it had little effect on those of B3. cpt-cAMP alone (500 M; n ϭ 6 for B3 and n ϭ 7 for B38) and the cpt-cAMP/IBMX mixture (each at 100 M; n ϭ 19) potentiated contractions evoked by both neurons. B: the latency between the onset of the burst and onset of the B38-evoked contraction was reduced by IBMX alone (n ϭ 5), cpt-cAMP alone (n ϭ 7), and the cpt-cAMP/IBMX mixture (n ϭ 20). This latency for B3 was also reduced by cpt-cAMP (n ϭ 6) and the cpt-cAMP/IBMX mixture (n ϭ 20), whereas IBMX had no effect (n ϭ 4). C: the time constant for the relaxation of contractions tended to be reduced by IBMX alone (n ϭ 4 for B3 and n ϭ 5 for B38), cpt-cAMP alone (n ϭ 6 for B3 and n ϭ 7 for B38), and the cpt-cAMP/IBMX mixture (n ϭ 20 for B3 and n ϭ 19 for B38) for both neurons. Decreased time constant indicates an increased relaxation rate. The percent change was calculated using the contractions before the application of the test agent as controls.
itate B38-evoked EJPs (Fig. 6B) . Whereas the cpt-cAMP/IBMX mixture was much more effective at facilitating EJPs than IBMX alone, the effects of the cpt-cGMP/IBMX mixture on B38-evoked EJPs was not significantly different from IBMX alone. These results indicate that in this preparation cpt-cAMP appears to act through the cAMP pathway.
The membrane-permeable cAMP analogues also potentiated contractions evoked by B3 or B38. cpt-cAMP (500 M) potentiated contractions evoked by both neurons to a similar degree (Figs. 7 and 8) . The effects of cpt-cAMP on contraction latency and relaxation rate were inconsistent. The latency was significantly reduced only for the B3-evoked contractions and the relaxation time constant only for B38-evoked contractions (Fig. 8) . The weak effects of cpt-cAMP on contractions might be due to limited diffusion across the cell membrane or its rapid degradation by phosphodiesterases (Sandberg et al. 1991) . We believe that potentiation was not mediated by the extracellular effects of cpt-cAMP because cAMP (500 M), which poorly diffuses across the cell membrane (Sandberg et al. 1991) , had no effect on contractions. Potentiation of contractions by cpt-cAMP was enhanced and made more consistent by co-application with IBMX. Simultaneous application of a lower concentration of cpt-cAMP (100 M) with IBMX (100 M) increased both B3-and B38-evoked contractions to a degree similar to the higher concentration of cpt-cAMP alone. Surprisingly, contractions evoked by stimulating B3 were potentiated more than those of B38 (Figs. 7 and 8) . The latency and the relaxation time constant were also reduced to a similar degree for both neurons (Figs. 7 and 8 ). The potentiation caused by cpt-cAMP/IBMX application was not due to activation of extracellular purinergic receptors because the application of cAMP and adenosine (each at 100 M) had no effect on contractions. Thus the short-term effects of cpt-cAMP/IBMX, although not identical, were qualitatively similar to the shortterm effects of 5-HT and SCP. They selectively facilitated B38-evoked EJPs and increased the relaxation rate of contractions for both neurons. Although cpt-cAMP/IBMX potentiated contractions and reduced the latency for both neurons, the effects on B3-evoked contractions were larger than predicted based on the actions of 5-HT and SCP in this preparation. These differences could be due to some nonspecific effects of cpt-cAMP (see DISCUSSION) .
In summary, there is good evidence that activation of the cAMP pathway can modulate EJPs and contractions in buccal muscle I3a. The short-term effects of 5-HT and SCP were mimicked well by procedures that increased cAMP levels or by cAMP analogues. Taken together with the observation that 5-HT and SCP (at 1 M) potently elevate the cAMP concentration in the muscle, these results suggest that 5-HT and SCP modulate EJPs and contractions, at least in part, via the cAMP second-messenger pathway. FIG. 9. Effects of phorbol esters on EJPs recorded extracellularly in I3a muscle with a perfusion electrode. A: 4␤-phorbol 12,13 diacetate (0.3 M; ␤-PDA) facilitated EJPs evoked by B3 or B38 to a similar degree. B: 4␣-phorbol 12,13 diacetate (3 M; ␣-PDA), a phorbol isomer that does not activate protein kinase C (PKC), had no effect on EJPs even though it was used at a 10-fold higher concentration, suggesting that the facilitation was caused by the activation PKC. EJPs were evoked by alternately stimulating B3 or B38 (interburst interval of 50 s). Bursts were at 16 Hz, and the burst durations were adjusted so the control compound EJPs were similar in amplitude. Recordings for A and B are from different experiments. Pooled results are presented in Fig. 10 . FIG. 10. Summary of the effects of phorbol esters on extracellularly recorded EJPs. Two different active derivatives of phorbol, 4␤-phorbol 12,13 diacetate (␤-PDA; n ϭ 3 for 0.3 and 3 M) and 12-deoxyphorbol 13-isobuterate (DPIB; n ϭ 3) facilitated EJPs evoked by B3 and B38 to a similar degree. An inactive isomer of phorbol, 4␣-phorbol 12,13 diacetate (␣-PDA; n ϭ 3), had no effect on EJPs evoked by either neuron. The mean amplitude of the 3rd EJPs in the bursts were used because the 1st EJP was often too small to measure reliably (e.g., Fig. 9 ). Increases were calculated using the EJP amplitude before the application of the test agent as the control.
Activation of the protein kinase C (PKC) pathway facilitates EJPs, but is not selective for B38
Some of the effects of 5-HT appear to be mediated by a second-messenger system other than cAMP pathway because low concentrations of 5-HT (Յ0.1 M) effectively modulate EJPs and contractions (Fox and Lloyd 1998) , whereas they have little effect on cAMP in the muscle. Because the activation of both PKA and PKC by 5-HT has been implicated in the facilitation of central sensory neuron synapses in Aplysia (Byrne and Kandel 1996; Ghirardi et al. 1992; Sugita et al. 1992 Sugita et al. , 1997a , we examined whether the activation of PKC facilitated EJPs. Indeed, 4␤-phorbol 12,13 diacetate (␤-PDA), used at concentrations necessary to reliably activate PKCmediated processes in intact ganglia (3 M) (Sugita et al. 1992 (Sugita et al. , 1994b , dramatically facilitated EJPs evoked by both neurons to a similar degree (Figs. 9 and 10 ). This differs from 5-HT and SCP, which selectively facilitated B38-evoked EJPs. Lower concentrations of ␤-PDA (0.3 M) were also effective at facilitating EJPs evoked by the two neurons (Fig. 10) . This facilitation appears to be due to activation of PKC because a phorbol isomer that does not activate PKC, 4␣-phorbol 12,13 diacetate (␣-PDA; 3 M), did not affect EJPs evoked by either neuron (Fig. 10) . A second phorbol derivative that is more selective in activating PKC, 12-deoxyphorbol 13-isobuterate (DPIB; 0.3 M), also facilitated EJPs evoked by both neurons (Fig. 10) . Thus activation of PKC appears capable of facilitating EJPs, but was not selective for B38.
We also looked at the effects of kinase inhibitors on EJPs. The broad spectrum kinase inhibitor H7 (Hidaka et al. 1984) had variable effects but clearly facilitated EJPs in some preparations (by as much as 367% at 100 M and 471% at 500 M). Chelerythrine, a relatively specific PKC inhibitor (Herbert et al. 1990 ), also facilitated EJPs (increased 29 Ϯ 3% at 30 M and 111 Ϯ 10% at 100 M; n ϭ 2 for each). We did not further pursue the use of these inhibitors because they caused facilitation themselves.
Activation of the PKC pathway potentiates contractions, but does not increase relaxation rate
Next we examined the effects of phorbol on the properties of contractions evoked by B3 and B38. ␤-PDA (3 M) dramatically changed the dynamics of contractions in that short bursts that were barely above threshold for evoking a contraction before ␤-PDA application produced near maximal contractions that relaxed extremely slowly after its application. Therefore it was necessary to use lower concentrations to study its effects on contractions. We found that ␤-PDA, at 0.03 and 0.3 M, dramatically increased contraction amplitude and reduced the latency for both neurons (Figs. 11 and 12) . However, unlike 5-HT and SCP, phorbol did not increase the relaxation rate of the contractions. Indeed, the relaxation rate actually decreased during the 0.03 and 0.3 M ␤-PDA applications for both neurons (Fig. 12) . We believe that these effects were caused by the activation of PKC because ␣-PDA (3 M), the inactive phorbol isomer, had no significant effects on the amplitude, latency, or relaxation rate of contractions evoked by either neuron (Figs. 11 and 12) .
Many adenylyl cyclases interact with and are regulated by other second-messenger systems including the diacylglycerol (DAG)/PKC pathway (Cooper et al. 1995; Pieroni et al. 1993) . Indeed, activation of PKC with phorbol increased the level of cAMP in Aplysia sensory neurons (Sugita et al. 1997b ). Be- FIG. 11. Effects of phorbol esters on I3a muscle contractions. Muscle contractions were evoked by alternately stimulating B3 or B38 (interburst interval of 50 s). All bursts were at 16 Hz. Burst durations were adjusted so that control contractions evoked by B3 and B38 were similar in amplitude. A: ␤-PDA (0.03 M) potentiated both B3-and B38-evoked contractions to a similar degree. Bursts durations were 2 s for B3 and 2.3 s for B38. B: ␤-PDA reduced the latency between the onset of the motor neuron burst (vertical line) and the onset of the contraction (filled triangle). The latency to the onset of muscle contractions is emphasized by superimposing recordings of the control and modulated contractions at a fast time base and high gain. As a result, most of the contractions are off scale. Superfusion with ␤-PDA decreased the latency of muscle contractions evoked by both B3 and B38, unlike 5-HT, SCP, forskolin, or the membrane permeable cAMP analogues, which reduced the latency of B38-evoked contractions more than those evoked by B3. C: ␣-PDA (3 M) had little effect on contraction amplitude, suggesting that the potentiation was caused by the activation of PKC. The duration of bursts was 1.8 s for B3 and 1.9 s for B38. D: ␣-PDA (3 M) also had no effect on the onset of contractions. Recordings are from the same experiment. Pooled results are presented in Fig. 12 . A, ASW; ␣, 4␣-phorbol 12,13 diacetate; ␤, 4␤-phorbol 12,13 diacetate.
cause phorbol can activate the cAMP pathway, we tested whether it increased the concentration of cAMP in I3a. ␤-PDA does not appear to act through the cAMP pathway because it only slightly increased the level of cAMP by 13 Ϯ 9% at 0.3 M (n ϭ 4; P Ͼ 0.05) and 24 Ϯ 12% at 3 M (n ϭ 4; P Ͼ 0.05). Thus facilitation of EJPs by phorbol differs from the actions of 5-HT, SCP, and activators of the cAMP pathway because phorbol facilitated the EJPs and reduced the contraction latency of both motor neurons to a similar degree. The nonselective facilitation of EJPs and the nonselective reduction in latency caused by phorbol supports our hypothesis that selective facilitation of B38-evoked EJPs leads to the selective reduction in latency produced by 5-HT, SCP, and agents that activate the cAMP pathway. Modulation by phorbol, without a concurrent increase in the cAMP levels in the muscle, suggests that there are mechanisms other than the cAMP pathway that can modulate EJPs and contractions.
D I S C U S S I O N
The effects of SCP appear to be mediated by the activation of the cAMP pathway. SCP, at concentrations as low as 0.01 M, increased the level of cAMP in I3a (Lotshaw and Lloyd 1990) , and activation of the cAMP pathway, with agents that bypass the SCP receptor and directly activate either adenylyl cyclase or PKA, mimicked the short-term effects of SCP. Activation of the cAMP pathway also mimicked the short-term effects of 1 M 5-HT; however, it is unlikely that the effects of lower concentrations of 5-HT (Յ0.1 M) are mediated by this pathway because, at these concentrations, 5-HT has little effect on the cAMP levels. Because phorbol dramatically facilitated EJPs and potentiated contractions, it is possible that low concentrations of 5-HT activate the PKC pathway.
Many of the effects of 5-HT or SCP are mediated postsynaptically in the I3a muscle fibers. In previous studies, 5-HT and SCP were shown to increase the relaxation rate of contractions, potentiate contractions evoked by the bolus application of glutamate to isolated bundles of muscle fibers, and modulate some step(s) in excitation-contraction coupling because they potentiate B3-evoked contractions even when the B3-evoked EJPs were essentially unchanged Fox and Lloyd 1997; Lotshaw and Lloyd 1990) . In the present study we have shown that 1 M 5-HT or SCP elevate cAMP levels in the I3a neuromuscular preparation over 250-fold above control values. This preparation contains both muscle fibers and the axons and terminals of neurons that innervate them. Considering the magnitude of the increase in the cAMP levels, it must occur primarily in muscle fibers because they represent nearly the entire tissue volume. It is unlikely that an increase in cAMP exclusively in the axons and terminals of neurons could account for the measured increase in cAMP because of their small volume. It is still possible that cAMP levels increased in the axons and terminals of neurons; however, in this preparation, the concentration of cAMP in neuronal terminals cannot be measured independently. Observations made in another buccal muscle in Aplysia (termed I5 or ARC) support the conclusion that most of the increase in cAMP levels is postsynaptic. 5-HT and SCP also potently increase the level of cAMP in I5, and an increase in cAMP was also observed in dissociated muscle fibers (Brezina et al. 1994a,b; Lloyd et al. 1984; Weiss et al. 1979; Whim and Lloyd 1989) . In addition, application of 5-HT and SCP also leads to the phosphorylation of a contractile protein that is believed to mediate the increase in relaxation rates . FIG. 12. Summary of the effects of phorbol esters on contraction amplitude, latency, and relaxation time constant. A: contractions of both B3 and B38 were potentiated by 0.03 M (n ϭ 6 for B3 and n ϭ 4 for B38) and 0.3 M 4␤-phorbol 12,13 diacetate (␤-PDA; n ϭ 7). The potentiation of contractions appears to be caused by the activation of PKC because ␣-PDA had no effect even at much higher concentrations (n ϭ 6 for B3 and n ϭ 3 for B38). B: the latency between the onset of the burst and onset of the B3-or B38-evoked contractions was reduced to a similar degree by ␤-PDA (0.03 M, n ϭ 4; 0.3 M, n ϭ 6 for B3 and n ϭ 6 for B38). The inactive phorbol isomer, ␣-PDA had little effect at much higher concentrations (n ϭ 4). C: the time constant for the relaxation of contractions tended to be increased by ␤-PDA (0.03 M, n ϭ 4 for B3 and n ϭ 3 for B38; 0.3 M, n ϭ 5 for B3 and n ϭ 6 for B38) for both neurons, whereas ␣-PDA (n ϭ 3 for B3 and n ϭ 4 for B38) had no effect. Increased time constant indicates a decrease in the relaxation rate. The percent change was calculated using the contractions before the application of the test agent as controls.
Two different procedures were used to bypass the 5-HT and SCP receptors and stimulate the cAMP pathway, activation of adenylyl cyclase by forskolin and application of cAMP analogues. Both procedures yielded similar results. Individually, each of the agents used in this study may have effects unrelated to their actions on the cAMP pathway. Forskolin activates adenylyl cyclase but has also been shown to affect both voltage-gated and ligand-gated currents in a cAMP-independent manner (Baxter and Byrne 1990b; Brezina et al. 1994a,b; Laurenza et al. 1989 ). We used dideoxy-forskolin, which has many of the cAMP-independent effects of forskolin but does not activate adenylyl cyclase as a control and found it had little effect. Dideoxy-forskolin (100 M) does significantly reduce voltage-gated currents in another buccal muscle (Brezina et al. 1994a,b) ; however, we used lower concentrations and found that they had little effect on EJPs and contractions in I3a. In addition, two hydrophilic derivatives of forskolin that activate adenylyl cyclase but have fewer nonspecific effects were also found to mimic forskolin. cpt-cAMP also has effects unrelated to its actions on the cAMP pathway. It has been shown to inhibit cGMP-specific phosphodiesterases (Connolly et al. 1992) , directly activate PKG (Sandberg et al. 1991) , and affect both voltage-and ligand-gated channels in a cAMP-independent manner (Brezina et al. 1994a,b; Lambert and Harrison 1990) . Some of these PKA-independent effects appear to be associated with the p-chlorophenylthio moiety because cpt-cGMP had similar effects, whereas cAMP, 8-bromo-cAMP, or 8-bromo-cGMP do not (Sugita et al. 1994a) . Although cpt-cAMP has many nonspecific effects, we believe that its effects on EJPs and contractions were mediated by the cAMP pathway for several reasons. 1) BiMPS, a different membrane-permeable cAMP analogue that does not activate PKG and does not contain the p-chlorophenylthio moiety (Sandberg et al. 1991) , also selectively facilitated B38 evoked EJPs. 2) cpt-cGMP is much less effective at facilitating EJPs than cpt-cAMP. 3) IBMX and cpt-cAMP do not act extracellularly at purinergic receptors. Two native purinergic agonists, adenosine and ATP, had no effect on EJPs even though they were used at the same concentration as IBMX and cpt-cAMP and are structurally similar to them. When the results are viewed collectively, they provide good evidence in support of a prominent role for the cAMP pathway in mediating many of the actions of 5-HT or SCP.
Cyclic nucleotides gated channels have been found in a variety of sensory and nonsensory tissues including vertebrate muscle and invertebrate neurons (Biel et al. 1994 (Biel et al. , 1999 Kehoe 1990; Price and Goldberg 1993; Sudlow et al. 1993; Zufall et al. 1997) . Therefore it is possible that cAMP modulates EJPs and contractions by directly gating ion channels. We could not determine whether cAMP acted directly on channels, if it acted through PKA, or a combination of both mechanisms. However, we believe that PKA has an important role in the modulation of I3a contractions based partially on results obtained in another buccal muscle (I5). In both muscles, 5-HT and SCP increase the levels of cAMP, increase contraction amplitude, and increase the relaxation rates of contractions (Fox and Lloyd 1997; Kupfermann 1997; Lotshaw and Lloyd 1990; Weiss et al. 1992) . In I5, SCP application leads to the activation of PKA, and application of either SCP or 5-HT causes the phosphorylation of a contractile protein termed twitchin Probst et al. 1994) . The degree and time course of the phosphorylation of twitchin correlates well with the increase in the relaxation rates . By contrast, the role of PKA in the facilitation of EJPs is uncertain because the locus of facilitation has not been identified in I3, and EJPs in I5 are only slightly facilitated by 5-HT and SCP making it a poor model for facilitation (Fox and Lloyd 1997; Lloyd et al. 1984; Weiss et al. 1978) .
Second-messenger systems other than the cAMP pathway may be involved in the plasticity at I3a neuromuscular synapses. Phorbol isomers that activate PKC modulated EJPs and contractions evoked by both B3 and B38. However, the effects of phorbol were different from those of 5-HT or SCP because phorbol facilitated EJPs and reduced the latency of contractions equally for both motor neurons. Phorbol also did not increase the relaxation rate of contractions. The differences between the actions of phorbol and 5-HT do not preclude PKC as a mediator of the effects of 5-HT. It is possible that B3 synapses do not express 5-HT receptors linked to this pathway or that phorbol activates PKC isoforms that are not normally activated by 5-HT. For example, sensory neurons in Aplysia contain both Ca-dependent and Ca-independent isoforms of PKC, and 5-HT activates only the Ca-dependent isoform of PKC, but phorbol activates both isoforms (Kruger et al. 1991; Sossin and Schwartz 1992) . Our results also suggest that 5-HT could act through second-messenger pathways other than the cAMP pathway. First, 0.1 M 5-HT and SCP have large modulatory effects on I3a Lloyd 1998, Lotshaw and ), but 5-HT does not significantly elevate the level of cAMP, whereas 0.1 M SCP causes a large increase in cAMP levels. In addition, activation of the PKC pathway facilitated EJPs and potentiated contractions without elevating cAMP levels. Both of these second-messenger pathways probably participate in the modulation of feeding by the MCCs because the maximal short-term effects of MCC stimulation were similar to those of 0.1-0.3 M 5-HT (Fox and Lloyd 1998) ; however, our data suggest that the cAMPindependent pathway is more important at physiological frequencies. Of course, the possibility remains that 5-HT might function solely through cAMP if, for example, the increase in cAMP caused by low concentrations of 5-HT was highly compartmentalized.
In many ways, these results are reminiscent of the facilitation observed in the central ganglia of Aplysia. PKA and PKC are thought to be involved in mediating the 5-HT-induced facilitation of excitatory postsynaptic potentials (EPSPs) between sensory and motor neurons (Byrne and Kandel 1996) . The two pathways were once thought to be activated serially with activation of the PKA leading to PKC activation (Goldsmith and Abrams 1991). Results from other work suggest that both pathways are activated in parallel (Braha et al. 1993; Ghirardi et al. 1992; Sacktor and Schwartz 1990) . More recent evidence suggests that both pathways function in parallel but that there is considerable cross-talk between them. Indeed, activation of PKC with phorbol attenuates subsequent responses to 5-HT and raises cAMP concentrations in sensory neurons (Sugita et al. 1997b ). Activation of PKC has also been shown to increase adenylyl cyclase activity and increase the cAMP concentration in other systems (Cooper et al. 1995; Pieroni et al. 1993 ). However, this does not appear to be the case in the I3a neuromuscular preparation because phorbol had little effect on cAMP levels. Furthermore, the effects of phorbol on EJPs were different from the effects of activators of the cAMP pathway. Phorbol equally facilitated EJPs evoked by B3 and B38, whereas 5-HT, SCP, forskolin, and cAMP analogues selectively facilitated B38-evoked EJPs.
Modulation of EJPs and contractions by both the cAMP and PKC pathways has been observed in two other wellstudied invertebrate neuromuscular preparations. In lobster, 5-HT facilitates EJPs, increases the tone of muscle, and increases the level of cAMP in both motor neurons and muscle fibers (Goy and Kravitz 1989; Goy et al. 1984; Hempel et al. 1996) . Activation of the cAMP pathway with forskolin, IBMX, or 8-bromo-cAMP only partially mimicked the actions of 5-HT. These pharmacological agents had no effect on muscle tone and did not facilitate EJPs to the same degree as 5-HT, suggesting that a component of the facilitation was cAMP-independent (Goy and Kravitz 1989) . Similar results have been obtained from the crayfish neuromuscular junction. The facilitation induced by 5-HT in the crayfish has been divided into two phases: early and late. Although the early phase of facilitation is mimicked by activators of the PKC pathway, the late phase facilitation requires the activation of both the cAMP and PKC pathways (Dixon and Atwood 1989a-c) . In addition, the cAMP pathway also modulates vertebrate muscle preparations. Activation of the cAMP pathway modulates electrical and contractile properties of the heart and skeletal muscles (McDonald et al. 1994; Osterrieder et al. 1982; Rodger and Bowman 1983; Tsien 1977) .
In conclusion, we provided additional evidence that pharmacological agents that activate the cAMP pathway mimicked most of the effects of 5-HT or SCP. However, it seems likely that some effects of 5-HT are also mediated through another second-messenger pathway because low concentrations of 5-HT modulate EJPs and contractions but do not increase cAMP. It is possible that lower concentrations of 5-HT function through receptors linked to the PKC pathway because phorbol modulated EJPs and contractions without increasing the levels of cAMP. Therefore more than one second-messenger system appears to modulate synaptic efficacy in the I3a neuromuscular system.
